Wed, Sep 17, 2014, 7:21 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Agenus Inc. Message Board

  • eiretekk eiretekk Sep 5, 2013 10:10 AM Flag

    Don't bury the body yet

    "In line with the Inependent Data Monitoring Committee's (IDMC) unanimous recommendation, GSK will continue the DERMA trial until the second co-primary endpoint is assessed. This endpoint, DFS in the gene signature positive sub-population, is designed to identify a subset of MAGE-A3 positive patients that may benefit from the treatment. Results from this analysis are expected in 2015. Until then, GSK will remain blinded to all safety and efficacy data. "

 
AGEN
2.99-0.04(-1.32%)Sep 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.